|1||NCT02549209||Recruiting||Pembro/Carbo/Taxol in Endometrial Cancer||
||Other / Industry||
||46||Female||18 Years and older (Adult, Older Adult)||NCT02549209||BTCRC GYN15-013||August 22, 2017||December 1, 2019||December 2019||September 15, 2015||March 11, 2019||
|2||NCT03914612||Recruiting||Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer||
||NIH / Other||
||810||Female||18 Years and older (Adult, Older Adult)||NCT03914612||NCI-2019-02186
|July 16, 2019||June 30, 2023||June 30, 2023||April 15, 2019||September 20, 2019||
† Study has passed its completion date and status has not been verified in more than two years.